EFFECT OF PERSONALIZED GENOMIC-GUIDED CHEMOTHERAPY REGIMENS ON TREATMENT OUTCOMES IN BRCA-MUTATED BREAST CANCER PATIENTS. Axisjmbs 2025, 2 (1), 15-26.